HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Cardiology
Meta-analysis
DOACs versus VKAs for left ventricular thrombus management in adults
Newer Blood Thinners May Be Safer for Heart Clot Patients
A meta-analysis suggests DOACs may be a reasonable alternative to VKAs for left ventricular thrombus, with similar efficacy and potentially …
If you have a blood clot in your heart, newer blood thinners may be just as effective as warfarin with a lower risk of dangerous bleeding.
Frontiers
May 14, 2026
Cardiology
RCT
Adding low-dose rivaroxaban to DAPT did not significantly reduce LV thrombus in anterior STEMI patients
Adding low-dose rivaroxaban to standard heart attack drugs did not clearly prevent blood clots in the heart
This randomized clinical trial evaluated 560 patients with anterior ST-segment elevation myocardial infarction (STEMI) across 29 centers in …
Adding a low-dose blood thinner to standard heart attack drugs did not clearly prevent dangerous clots in the heart, based on a trial of 560…
JAMA Cardiol
Apr 9, 2026